Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.77
0.03 (4.58%)
At close: Aug 15, 2025, 10:05 AM

Context Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
94.43M 14.45M 35.5M 49.64M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 50.39K
Other Long-Term Assets
n/a n/a 32.75K n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
3.47M 1.6M 2.36M n/a
Total Current Assets
97.9M 16.05M 37.85M 51.26M
Property-Plant & Equipment
230.78K 15.52K 79.53K n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
230.78K 15.52K 112.28K 50.39K
Total Assets
98.13M 16.06M 37.97M 51.31M
Account Payables
1.45M 2.38M 936.33K 1.83M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
107.32K n/a n/a n/a
Other Current Liabilities
1.19M 661.3K 1.39M 85.53K
Total Current Liabilities
2.75M 4.19M 3.21M 3.03M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
112.06K n/a n/a n/a
Total Liabilities
2.86M 4.19M 3.21M 3.03M
Total Debt
219.38K n/a 55.08K n/a
Common Stock
89.7K 15.97K 15.97K 15.97K
Retained Earnings
-94.78M -68.05M -44.09M -29.25M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
95.27M 11.87M 34.76M 48.27M
Total Investments
n/a n/a n/a 50.39K